End-of-life care for people with chronic kidney disease: cause of death, place of death and hospital costs
- PMID: 27207901
- DOI: 10.1093/ndt/gfw098
End-of-life care for people with chronic kidney disease: cause of death, place of death and hospital costs
Abstract
Background: End-of-life care for people with chronic kidney disease (CKD) has been identified as an area of great clinical need internationally. We estimate causes and place of death and cost of hospital care for people with CKD in England in the final 3 years of life.
Methods: Hospital Episode Statistics data were linked to Office for National Statistics mortality data to identify all patients in England aged ≥18 years who died 1 April 2006-31 March 2010, and had a record of hospital care after 1 April 2003 (the study group). The underlying cause and place of death were examined in Office for National Statistics data, for patients without and with CKD (identified by International Classification of Diseases version 10 codes N18, I12 and I13). Costs of hospital admissions and outpatient attendances were estimated using National Health Service Reference Cost data. Associations between CKD and hospital costs, and between place of death and hospital costs in those with CKD, were examined using multivariate regressions.
Results: There were 1 602 105 people in the study group. Of these, 13.2% were recorded as having CKD. The proportion of deaths at home was 10.7% in people with CKD and 17.2% in the age- and gender-matched non-CKD group. Regression analysis suggests that CKD was associated with an increase in hospital costs of £3380 in the last 12 months of life, holding constant place of death, comorbidities and other variables. For the CKD group, home death was associated with a reduction in hospital costs of £2811 in the 12 months before death. The most commonly recorded cause of death in people with CKD was heart disease. CKD was not mentioned on the death certificate in two-thirds of deaths in people with the condition.
Conclusions: People with CKD are less likely to die at home than those without CKD. The condition is associated with increased hospital costs at the end of life regardless of place of death. Home death in CKD is associated with a substantial reduction in hospital costs at the end of life.
Keywords: chronic kidney disease; costs; end of life; health economics.
© The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
Similar articles
-
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?BMC Nephrol. 2015 Apr 29;16:65. doi: 10.1186/s12882-015-0054-0. BMC Nephrol. 2015. PMID: 25924679 Free PMC article.
-
Effect of a home-based end-of-life nursing service on hospital use at the end of life and place of death: a study using administrative data and matched controls.BMJ Support Palliat Care. 2013 Dec;3(4):422-30. doi: 10.1136/bmjspcare-2012-000424. Epub 2013 Jun 6. BMJ Support Palliat Care. 2013. PMID: 24950522
-
Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data.NPJ Prim Care Respir Med. 2017 Mar 3;27(1):14. doi: 10.1038/s41533-017-0017-y. NPJ Prim Care Respir Med. 2017. PMID: 28258277 Free PMC article.
-
Costs of care at the end of life among elderly patients with chronic kidney disease: patterns and predictors in a nationwide cohort study.BMC Nephrol. 2017 Jan 26;18(1):36. doi: 10.1186/s12882-017-0456-2. BMC Nephrol. 2017. PMID: 28122500 Free PMC article.
-
Geographical and temporal Understanding In place of Death in England (1984–2010): analysis of trends and associated factors to improve end-of-life Care (GUIDE_Care) – primary research.Southampton (UK): NIHR Journals Library; 2014 Nov. Southampton (UK): NIHR Journals Library; 2014 Nov. PMID: 25642511 Free Books & Documents. Review.
Cited by
-
Impact of chronic kidney disease on mortality: A nationwide cohort study.Kidney Res Clin Pract. 2019 Sep 30;38(3):382-390. doi: 10.23876/j.krcp.18.0128. Kidney Res Clin Pract. 2019. PMID: 31382730 Free PMC article.
-
The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review.PLoS One. 2020 Mar 24;15(3):e0230512. doi: 10.1371/journal.pone.0230512. eCollection 2020. PLoS One. 2020. PMID: 32208435 Free PMC article.
-
Advance care planning for patients with end-stage kidney disease on dialysis: narrative review of the current evidence, and future considerations.J Nephrol. 2024 Apr;37(3):547-560. doi: 10.1007/s40620-023-01841-3. Epub 2024 Jan 18. J Nephrol. 2024. PMID: 38236475 Free PMC article. Review.
-
CKD Progression Risk and Subsequent Cause of Death: A Population-Based Cohort Study.Kidney Med. 2023 Jan 21;5(4):100604. doi: 10.1016/j.xkme.2023.100604. eCollection 2023 Apr. Kidney Med. 2023. PMID: 36970224 Free PMC article.
-
Cost-effectiveness analysis of targeted-release formulation of budesonide (Tarpeyo) in conjunction with optimized renin-angiotensin system inhibitor (RASi) therapy relative to optimized RASi therapy alone for adults with primary immunoglobulin A nephropathy in the United States.J Manag Care Spec Pharm. 2025 May;31(5):499-509. doi: 10.18553/jmcp.2025.31.5.499. J Manag Care Spec Pharm. 2025. PMID: 40298312 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous